Lv11
40 积分 2022-05-19 加入
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
2小时前
待确认
Targeting ARID1A mutations in cancer
2个月前
已完结
Brief update of the new WHO classification for urothelial carcinoma
2个月前
已完结
Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium
2个月前
已完结
Molecular subtyping in urothelial carcinoma treatment
3个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
3个月前
已完结
Synthesis and in vitro anticancer activity of some 2-oxindoline derivatives as potential CDK2 inhibitors
4个月前
已完结
Progresses in the establishment, evaluation, and application of in vitro blood–brain barrier models
4个月前
已完结
Abstract ND11: Chemoproteomic-enabled discovery of VVD-214, a synthetic lethal allosteric inhibitor of WRN helicase
6个月前
已关闭
Evaluating TRKB activity of novel preclinical brain-penetrant ROS1 and ALK inhibitors
6个月前
已关闭
皖公网安备34019202002308
